Literature DB >> 19052375

Crystallization and preliminary X-ray analysis of the human androgen receptor ligand-binding domain with a coactivator-like peptide and selective androgen receptor modulators.

Maxime Thauvin1, Catherine Robin-Jagerschmidt, François Nique, Patrick Mollat, Damien Fleury, Thierry Prangé.   

Abstract

The ligand-binding domain of the human androgen receptor has been cloned, overproduced and crystallized in the presence of a coactivator-like 11-mer peptide and two different nonsteroidal ligands. The crystals of the two ternary complexes were isomorphous and belonged to space group P2(1)2(1)2(1), with one molecule in the asymmetric unit. They diffracted to 1.7 and 1.95 A resolution, respectively. Structure determination of these two complexes will help in understanding the mode of binding of selective nonsteroidal androgens versus endogenous steroidal ligands and possibly the origin of their tissue selectivity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19052375      PMCID: PMC2593712          DOI: 10.1107/S1744309108036683

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  19 in total

1.  Effect of testosterone treatment on bone mineral density in men over 65 years of age.

Authors:  P J Snyder; H Peachey; P Hannoush; J A Berlin; L Loh; J H Holmes; A Dlewati; J Staley; J Santanna; S C Kapoor; M F Attie; J G Haddad; B L Strom
Journal:  J Clin Endocrinol Metab       Date:  1999-06       Impact factor: 5.958

2.  Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

Authors:  Christina Wang; Glenn Cunningham; Adrian Dobs; Ali Iranmanesh; Alvin M Matsumoto; Peter J Snyder; Thomas Weber; Nancy Berman; Laura Hull; Ronald S Swerdloff
Journal:  J Clin Endocrinol Metab       Date:  2004-05       Impact factor: 5.958

3.  Discovery of 6-N,N-bis(2,2,2-trifluoroethyl)amino- 4-trifluoromethylquinolin-2(1H)-one as a novel selective androgen receptor modulator.

Authors:  Arjan van Oeveren; Mehrnouch Motamedi; Neelakandha S Mani; Keith B Marschke; Francisco J López; William T Schrader; Andrés Negro-Vilar; Lin Zhi
Journal:  J Med Chem       Date:  2006-10-19       Impact factor: 7.446

4.  Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone.

Authors:  J S Sack; K F Kish; C Wang; R M Attar; S E Kiefer; Y An; G Y Wu; J E Scheffler; M E Salvati; S R Krystek; R Weinmann; H M Einspahr
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 5.  Androgen deficiency in the aging male: benefits and risks of androgen supplementation.

Authors:  Louis Gooren
Journal:  J Steroid Biochem Mol Biol       Date:  2003-06       Impact factor: 4.292

6.  Comparison of crystal structures of human androgen receptor ligand-binding domain complexed with various agonists reveals molecular determinants responsible for binding affinity.

Authors:  Karine Pereira de Jésus-Tran; Pierre-Luc Côté; Line Cantin; Jonathan Blanchet; Fernand Labrie; Rock Breton
Journal:  Protein Sci       Date:  2006-05       Impact factor: 6.725

7.  FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor.

Authors:  B He; J A Kemppainen; E M Wilson
Journal:  J Biol Chem       Date:  2000-07-28       Impact factor: 5.157

Review 8.  Localization of androgen and estrogen receptors in rat and primate tissues.

Authors:  G Pelletier
Journal:  Histol Histopathol       Date:  2000-10       Impact factor: 2.303

Review 9.  Molecular pathology of the androgen receptor in male (in)fertility.

Authors:  Bruce Gottlieb; Rose Lombroso; Lenore K Beitel; Mark A Trifiro
Journal:  Reprod Biomed Online       Date:  2005-01       Impact factor: 3.828

Review 10.  Mechanism of action and pure antiandrogenic properties of flutamide.

Authors:  F Labrie
Journal:  Cancer       Date:  1993-12-15       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.